
In vivo imaging of CT26 mouse tumours by using cmHsp70.1 monoclonal antibody
Author(s) -
Stangl Stefan,
Gehrmann Mathias,
Dressel Ralf,
Alves Frauke,
Dullin Christian,
Themelis George,
Ntziachristos Vasilis,
Staeblein Eva,
Walch Axel,
Winkelmann Isabel,
Multhoff Gabriele
Publication year - 2011
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/j.1582-4934.2010.01067.x
Subject(s) - monoclonal antibody , internalization , fluorescein isothiocyanate , microbiology and biotechnology , hsp70 , antibody , in vivo , endosome , cytotoxicity , chemistry , in vitro , cell , biology , heat shock protein , immunology , biochemistry , fluorescence , physics , quantum mechanics , gene
The major stress‐inducible heat shock protein 70 (Hsp70) is frequently present on the cell surface of human tumours, but not on normal cells. Herein, the binding characteristics of the cmHsp70.1 mouse monoclonal antibody (mAb) were evaluated in vitro and in a syngeneic tumour mouse model. More than 50% of the CT26 mouse colon carcinoma cells express Hsp70 on their cell surface at 4°C. After a temperature shift to 37°C, the cmHsp70.1‐fluorescein isothiocyanate mAb translocates into early endosomes and lysosomes. Intraoperative and near‐infrared fluorescence imaging revealed an enrichment of Cy5.5‐conjugated mAb cmHsp70.1, but not an identically labelled IgG1 isotype‐matched control, in i.p. and s.c. located CT26 tumours, as soon as 30 min. after i.v. injection into the tail vein. Due to the rapid turnover rate of membrane‐bound Hsp70, the fluorescence‐labelled cmHsp70.1 mAb became endocytosed and accumulated in the tumour, reaching a maximum after 24 hrs and remained detectable at least up to 96 hrs after a single i.v. injection. The tumour‐selective internalization of mAb cmHsp70.1 at the physiological temperature of 37°C might enable a targeted uptake of toxins or radionuclides into Hsp70 membrane‐positive tumours. The anti‐tumoral activity of the cmHsp70.1 mAb is further supported by its capacity to mediate antibody‐dependent cytotoxicity.